Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Certara Inc
(NQ:
CERT
)
9.990
+0.030 (+0.30%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
948,833
Open
10.02
Bid (Size)
9.990 (5)
Ask (Size)
10.20 (9)
Prev. Close
9.960
Today's Range
9.820 - 10.11
52wk Range
9.820 - 19.87
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Forecasting The Future: 4 Analyst Projections For Certara
November 07, 2024
Via
Benzinga
Certara Reports Third Quarter 2024 Financial Results
November 06, 2024
Updates Full Year 2024 Financial Guidance
From
Certara
Via
GlobeNewswire
Performance
YTD
-42.42%
-42.42%
1 Month
-10.80%
-10.80%
3 Month
-19.44%
-19.44%
6 Month
-38.94%
-38.94%
1 Year
-32.09%
-32.09%
More News
Read More
Certara to Participate in the Stephens Annual Investment Conference
October 28, 2024
From
Certara
Via
GlobeNewswire
Certara Appoints John Reynders as New Independent Board Member
October 16, 2024
From
Certara
Via
GlobeNewswire
Beyond The Numbers: 4 Analysts Discuss Certara Stock
October 15, 2024
Via
Benzinga
Beyond The Numbers: 4 Analysts Discuss Certara Stock
September 27, 2024
Via
Benzinga
MaxCyte Appoints Cynthia Collins to its Board of Directors
October 15, 2024
From
MaxCyte, Inc
Via
GlobeNewswire
Certara to Report Third Quarter 2024 Financial Results on November 6th, 2024
October 09, 2024
From
Certara
Via
GlobeNewswire
Certara Completes Acquisition of Chemaxon
October 02, 2024
From
Certara
Via
GlobeNewswire
IonQ, Biomea Fusion, Rocket Lab USA And Other Big Stocks Moving Higher On Friday
September 27, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 27, 2024
Via
Benzinga
Certara’s Simcyp Consortium Celebrates 25th Anniversary
September 24, 2024
From
Certara
Via
GlobeNewswire
Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug
September 18, 2024
From
Certara
Via
GlobeNewswire
Certara to Participate in Upcoming Investor Conferences
August 21, 2024
From
Certara
Via
GlobeNewswire
Certara Launches Phoenix™ Version 8.5 Drug Development Software
August 15, 2024
From
Certara
Via
GlobeNewswire
CERT Stock Earnings: Certara Misses EPS, Misses Revenue for Q2 2024
August 06, 2024
Via
InvestorPlace
Certara Reports Second Quarter 2024 Financial Results
August 06, 2024
From
Certara
Via
GlobeNewswire
Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio
July 09, 2024
From
Certara
Via
GlobeNewswire
Simulations Plus Stock Drops 15% Despite EPS Beat
July 05, 2024
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Certara to Report Second Quarter 2024 Financial Results on August 6th, 2024
July 02, 2024
From
Certara
Via
GlobeNewswire
Certara Launches Next Generation CoAuthor™ Generative AI Regulatory Writing Software
June 17, 2024
From
Certara
Via
GlobeNewswire
Certara to Participate in the Jefferies Global Healthcare Conference
May 29, 2024
From
Certara
Via
GlobeNewswire
Certara Appoints New Chief Human Resources Officer & General Counsel
May 21, 2024
From
Certara
Via
GlobeNewswire
CERT Stock Earnings: Certara Meets EPS, Beats Revenue for Q1 2024
May 07, 2024
Via
InvestorPlace
Certara Reports First Quarter 2024 Financial Results
May 07, 2024
From
Certara
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.